Dyadic Announces Research, License and Collaboration Agreement with Janssen for the Manufacture of Therapeutic Protein Candidates using its C1 Platform
Dyadic Announces Research, License and Collaboration Agreement with Janssen for the Manufacture of Therapeutic Protein Candidates using its C1 Platform
Mark Emalfarb Dyadic International Inc Pingw Rawson Janssen Biotech Inc Dyadic International Inc Securities Exchange Janssen Pharmaceutical Companies Of Johnson
Source: medindia.net